Brain abscess: Difference between revisions
From IDWiki
mNo edit summary |
m (Text replacement - " species]]" to "]]") |
||
(11 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Background== |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*Direct spread (50%) |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*Hematogenous spread (25%) |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*Direct inoculation (10%) |
|||
⚫ | |||
⚫ | |||
*Cryptogenic (15%) |
|||
*Immunocompromised patient |
|||
**'''HIV:''' [[Toxoplasma gondii]], [[Nocardia]], [[non-tuberculous mycobacteria]], [[Listeria monocytogenes]], [[Cryptococcus neoformans]] |
|||
**'''Neutropenia:''' Gram-negative bacilli, [[Aspergillus]], [[mucormycosis]], [[Candida]], [[Scedosporium]] |
|||
**'''Transplantation:''' [[Aspergillus]], [[Candida]], [[mucormycosis]], [[Scedosporium]], [[Enterobacteriaceae]], [[Nocardia]], [[Toxoplasma gondii]], and [[Mycobacterium tuberculosis]] |
|||
⚫ | |||
*Other organisms: [[Nocardia]], [[Klebsiella pneumoniae]] (especially southeast Asia), [[Aspergillus]], [[Taenia solium]], and [[Toxoplasma gondii]] |
|||
===Pathophysiology=== |
|||
*Either from contiguous spread from a [[:Category:Head and neck infections|head and neck infection]], hematogenous spread from [[bacteremia]] or [[endocarditis]], traumatic inoculation, or post-neurosurgery |
|||
*Typically starts as a small focus of infection in the brain parenchyma, followed by cerebritis and eventual capsule formation to give an abscess |
|||
*Microbiology (above) depends on mechanism of infection |
|||
==Clinical Manifestations== |
|||
*Often non-specific |
|||
*Headache is most common, then fever and focal neurological deficits |
|||
*May have seizures |
|||
*May have symptoms of increase ICP, such as comiting, blurry vision, drowiness, and confusion |
|||
===Prognosis and Complications=== |
|||
*10% mortality |
|||
*50% seizures |
|||
*20% significant cognitive impairment |
|||
==Investigations== |
|||
*MRI with gadolinium |
|||
**Typically demonstrates a ring-enhancing lesion with thin rim |
|||
**Temporal lobe and cerebellum suggests contiguous spread from chronic otitis or mastoiditis |
|||
**Frontal and temporal lobe suggests contiguous spread from frontal or ethmoid sinusitis |
|||
**Frontal lobe and cerebellum can be secondary to meningitis |
|||
**Frontal lobe scan be from dental infection or manipulation |
|||
**Multiple abscesses in a middle cerebral artery distribution suggests bacteremia |
|||
*Blood cultures positive in 15% |
|||
*Lumbar puncture usually contraindicated due to mass effect and risk of herniation |
|||
*Most important is aspiration of abscess for stain and culture, which is positive in 2/3 of cases |
|||
**Can do bacterial or fungal ribosomal PCR if cultures negative |
|||
==Management== |
|||
*Empiric therapy is directed at the likely organisms based on etiology (direct vs. hematogenous spread) |
|||
**For likely oral, ear, or sinus source, treated with [[Is treated by::ceftriaxone]] and [[Is treated by::metronidazole]] at CNS doses |
|||
**For likely hematogenous spread, treated with [[Is treated by::vancomycin]] |
|||
**For uncertain etiology, combination of [[ceftriaxone]], [[metronidazole]], and [[vancomycin]] |
|||
**For neurosurgical patients, [[Is treated by::vancomycin]] plus a broad-spectrum [[Antipseudomonal antibiotics|antipseudomonal antibiotic]] such as [[Is treated by::ceftazidime]], [[Is treated by::cefepime]], or [[Is treated by::meropenem]] |
|||
*Source control with neurosurgical aspiration |
|||
*Duration is typically 6 to 8 weeks of intravenous antibiotics following source control |
|||
**Monitor with serial MRI, though abnormalities may persist after successful treatment |
|||
*No role for routine use of steroids |
|||
==Further Reading== |
|||
*Brain Abscesses. ''NEJM''. 2015;371:447-456. doi: [https://doi.org/10.1056/NEJMra1301635 10.1056/NEJMra1301635] |
|||
[[Category:CNS infections]] |
[[Category:CNS infections]] |
||
[[Category:Infectious diseases]] |
Latest revision as of 16:44, 25 January 2022
Background
Microbiology
- Direct spread (50%)
- Nose/sinuses: Streptococcus (especially Streptococcus anginosus group), Haemophilus, Bacteroides, Fusobacterium
- Teeth: Streptococcus, Bacteroides, Prevotella, Fusobacterium, Haemophilus
- Ears: Enterobacteriaceae, Streptococcus, Pseudomonas aeruginosa, Bacteroides
- Hematogenous spread (25%)
- Lungs: Streptococcus, Fusobacterium, Actinomyces
- Urinary tract: Pseudomonas aeruginosa, Enterobacter
- Endocarditis: Viridans group streptococci, Staphylococcus aureus
- Congenital cardiac malformations (especially right-to-left shunts): Streptococcus
- Direct inoculation (10%)
- Penetrating head trauma: Staphylococcus aureus, Enterobacter, Clostridium
- Neurosurgery: Staphylococcus, Streptococcus, Pseudomonas aeruginosa, Enterobacter
- Cryptogenic (15%)
- Immunocompromised patient
- HIV: Toxoplasma gondii, Nocardia, non-tuberculous mycobacteria, Listeria monocytogenes, Cryptococcus neoformans
- Neutropenia: Gram-negative bacilli, Aspergillus, mucormycosis, Candida, Scedosporium
- Transplantation: Aspergillus, Candida, mucormycosis, Scedosporium, Enterobacteriaceae, Nocardia, Toxoplasma gondii, and Mycobacterium tuberculosis
- Plus anaerobes, which are common
- Other organisms: Nocardia, Klebsiella pneumoniae (especially southeast Asia), Aspergillus, Taenia solium, and Toxoplasma gondii
Pathophysiology
- Either from contiguous spread from a head and neck infection, hematogenous spread from bacteremia or endocarditis, traumatic inoculation, or post-neurosurgery
- Typically starts as a small focus of infection in the brain parenchyma, followed by cerebritis and eventual capsule formation to give an abscess
- Microbiology (above) depends on mechanism of infection
Clinical Manifestations
- Often non-specific
- Headache is most common, then fever and focal neurological deficits
- May have seizures
- May have symptoms of increase ICP, such as comiting, blurry vision, drowiness, and confusion
Prognosis and Complications
- 10% mortality
- 50% seizures
- 20% significant cognitive impairment
Investigations
- MRI with gadolinium
- Typically demonstrates a ring-enhancing lesion with thin rim
- Temporal lobe and cerebellum suggests contiguous spread from chronic otitis or mastoiditis
- Frontal and temporal lobe suggests contiguous spread from frontal or ethmoid sinusitis
- Frontal lobe and cerebellum can be secondary to meningitis
- Frontal lobe scan be from dental infection or manipulation
- Multiple abscesses in a middle cerebral artery distribution suggests bacteremia
- Blood cultures positive in 15%
- Lumbar puncture usually contraindicated due to mass effect and risk of herniation
- Most important is aspiration of abscess for stain and culture, which is positive in 2/3 of cases
- Can do bacterial or fungal ribosomal PCR if cultures negative
Management
- Empiric therapy is directed at the likely organisms based on etiology (direct vs. hematogenous spread)
- For likely oral, ear, or sinus source, treated with ceftriaxone and metronidazole at CNS doses
- For likely hematogenous spread, treated with vancomycin
- For uncertain etiology, combination of ceftriaxone, metronidazole, and vancomycin
- For neurosurgical patients, vancomycin plus a broad-spectrum antipseudomonal antibiotic such as ceftazidime, cefepime, or meropenem
- Source control with neurosurgical aspiration
- Duration is typically 6 to 8 weeks of intravenous antibiotics following source control
- Monitor with serial MRI, though abnormalities may persist after successful treatment
- No role for routine use of steroids
Further Reading
- Brain Abscesses. NEJM. 2015;371:447-456. doi: 10.1056/NEJMra1301635